← Issue №18/ week of Nov 1, 2026/Hepatology

Effects of Aerobic Exercise on Autonomic and Endothelial Function and Splanchnic Hemodynamics in Compensated Cirrhosis: RCT Study.

From GI Signals issue №18: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Hepatology rct · n=50 · Nov 1, 2026 · Liver International · IF 6.7

Effects of Aerobic Exercise on Autonomic and Endothelial Function and Splanchnic Hemodynamics in Compensated Cirrhosis: RCT Study.

New evidencecirrhosisportal hypertension
Clinical takeawayConsider recommending a 16-week moderate-intensity aerobic exercise program (e.g., brisk walking) to improve functional capacity and portal vein hemodynamics in patients with compensated cirrhosis, while acknowledging the lack of between-group significance in autonomic and hepatic parameters.
What it foundAerobic exercise improved 6-minute walk test distance by 32 meters (IQR: 12.00-51.60 m, p < 0.01) compared to nutritional consultation alone and increased portal vein volume flow by 350.66 mL/min (p = 0.003) in compensated cirrhosis, though positive signals in autonomic and hepatic parameters were not between-group significant.
ContextThis RCT provides evidence that aerobic exercise is safe and beneficial in compensated cirrhosis, refining prior observational data on exercise in liver disease.
Measured against the standard of care· ACG 2026 (Tapper EB et al., ACG Clinical Guideline: Preventive Care for Patients With Cirrhosis, Am J Gastroenterol, online 2026-10-05)

… Carvedilol is also suggested in compensated cirrhosis with clinically significant portal hypertension to prevent a first episode of ascites; CSPH can be estimated noninvasively from transient elastography plus platelet count. … Structured aerobic and resistance exercise for ambulatory patients. …

From our summary of this standard, unedited — the part the paper bears on. … marks omitted text. Our wording, not the guideline's; read the source for its own text.

Our full summary of this standard

ACG 2026 (Tapper et al., Am J Gastroenterol, online 2026-10-05) gives 18 GRADE recommendations and 6 key concepts on preventive care in cirrhosis; most of the evidence is low certainty. Varices: carvedilol (12.5 mg daily, with no titration to a heart-rate target) or endoscopic variceal ligation as primary prophylaxis for high-risk esophageal varices. This is strong, and it is the only moderate-certainty recommendation. Carvedilol is also suggested in compensated cirrhosis with clinically significant portal hypertension to prevent a first episode of ascites; CSPH can be estimated noninvasively from transient elastography plus platelet count. HCC: ultrasound plus AFP every 6 months for patients who are candidates for HCC treatment (strong). Aspirin is not recommended for HCC prevention, and statins should not be started only for chemoprevention without a conventional cardiovascular indication. Vaccination: test hepatitis A immunity and vaccinate if not immune; annual influenza; a SARS-CoV-2 series; RSV (bivalent vaccine) at age 50 or older; all strong. Test hepatitis B immunity and vaccinate (conditional), and revaccinate non-responders, considering the TLR9-adjuvanted vaccine. Hepatic encephalopathy: lactulose over no treatment for minimal HE; no rifaximin for primary prevention in minimal HE; add rifaximin if overt HE develops on lactulose. Upper GI bleeding, variceal or not: a 2-3 day course of prophylactic antibiotics. Albumin 6-8 g per liter removed for paracentesis over 5 L. Nutrition: dietitian-guided, protein 1.2-1.5 g/kg ideal body weight per day and 30-35 kcal/kg per day, lower in obesity. Structured aerobic and resistance exercise for ambulatory patients. Bisphosphonates for osteoporosis; varices alone do not rule out oral bisphosphonates. Screen for alcohol use disorder at every visit, treat with naltrexone or acamprosate, and offer behavioral therapy after discharge to hospitalized patients with AUD. Smoking-cessation counseling (strong). Clinic follow-up within 14 days of discharge. Consider age-appropriate cancer screening for transplant candidates and for non-frail compensated patients without life-limiting comorbidity.

ACG 2026 (Tapper EB et al., ACG Clinical Guideline: Preventive Care for Patients With Cirrhosis, Am J Gastroenterol, online 2026-10-05) · reviewed 2026-10-11 ↗
Kittiprachakul S … Chaiteerakij R · Liver International : Official Journal of the International Association for the Study of the Liver · IF 6.7 · PubMed ↗Permalink
← Read the whole of issue №18 Every paper GI Signals surfaces gets a page like this one. All issues